Genesis Alkali announced June 20 that it has a definitive agreement with Cytozyme Laboratories Inc., a privately held company in Salt Lake City, Utah, to establish certain exclusive rights to market and distribute Cytozyme’s Lumensa for use in the poultry market.

According to the announcement from Genesis Alkali, the product is a natural feed additive that leverages three modes of action: improved gut integrity, a modified gut biome and the reduction of pathogens through competitive exclusion. These elements combine to support improved gut health and reduce the effects of stress to increase production, the company said.

“We are excited to bring Cytozyme’s innovative technology to the poultry market with Lumensa,” said Wendy Plocher, global animal nutrition industry manager for Genesis Alkali. “We look forward to working with producers to enable them to increase production and improve returns.”

Cytozyme has applied more than four decades of experience, knowledge and innovation in fermentation technology to create a diverse portfolio of animal nutrition products.

“The growing trend toward antibiotic-free (ABF) diets has brought demand for a greater degree of innovation and product development geared toward improving animal health and productivity through more natural and sustainable means,” said John Stockham, Cytozyme general manager of animal nutrition. “On behalf of Cytozyme, we are excited to contribute to this effort with the help of Genesis Alkali and their deep industry knowledge and relationships.”

As a supplier to the feed industry for more than 25 years, Genesis Alkali manufactures S-Carb (refined sodium sesquicarbonate) as well as feed-grade sodium bicarbonate, among other products. As part of Genesis Energy LP, it operates a multifaceted trona ore mining and production facility in Green River, Wyo.